GenScript Vizgen Plans Launch of Spatial Transcriptomics Platform Based on MERFISH Technology Premium The Harvard spinout wants its instrumentation and reagent packages to ease the transition for labs interested in high-resolution imaging studies. Molecular Assemblies Raising Cash, Awareness for Enzymatic DNA Synthesis Premium The San Diego-based DNA synthesis firm this week announced $12.2 million in Series A funding, but has plans to expand the round. In Brief This Week: 10x Genomics, Yourgene, HTG Molecular, GenScript, More GenScript to Acquire CustomArray GenScript believes that CustomArray's oligonucleotide synthesis and microarray manufacturing technology will enable it to better serve its customers. SGI-DNA Sees Deal With Belgium's VIB as Springboard to Building European Synthetic Genomics Business Premium The La Jolla, California-based firm is moving beyond its US home market into other regions that promise growth for synthetic genomics providers. Dec 14, 2012 In Brief This Week: Roche; Danaher; BG Medicine; Accelr8 Technology; Waters; GenScript; Gene By Gene Aug 24, 2012 In Brief This Week: Almac Diagnostics; Leica, Aperio; GenScript; University of Nebraska Oct 20, 2011 False-Marking Lawsuit Against Nucleic Acid Analysis Tool Providers Dropped Premium Jun 1, 2011 Evozym, GenScript Partner on Synthetic Biology Sep 3, 2010 New Products: Sep 3, 2010 Premium Jun 11, 2010 New Products: Jun 11, 2010 Premium Dec 29, 2009 Synthetic Gene Firms Get Ahead of Government on Security Nov 19, 2009 Gene Synthesis Companies to Develop Biothreat Protocols Breaking News Lander, Collins Offer Vision for Advanced Research Projects Agency for Health LetsGetChecked Partners With California Department of Public Health for COVID-19 Sequencing BTIG Initiates Coverage of Berkeley Lights With Buy Rating Quest Diagnostics to Offer Biocept's Target Selector NGS Lung Cancer Test Novacyt 2020 Revenues Surge on Strong Demand for SARS-CoV-2 Testing Products Leidos Wins CDC Bioinformatics Contract Worth up to $13M The Scan Could Cost Billions NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars. Not Quite Sent The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post. DTC Regulation Proposals A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports. PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.